Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med., 16 January 2024
Sec. Heart Valve Disease
This article is part of the Research Topic Reviews in Heart Valve Stenosis and Regurgitation View all 10 articles

Results of the inoperable and operable with aortic valve endocarditis

\r\nJing-bin Huang
&#x;Jing-bin Huang*Chang-chao Lu&#x;Chang-chao LuZhen-zong DuZhen-zong DuJian-rong YangJian-rong YangJun-jun Li\r\nJun-jun Li
  • Department of Cardiothoracic Surgery, The People’s Hospital of Guangxi Zhuang Autonomous Region, and Guangxi Academy of Medical Sciences, Nanning, Guangxi, China

Objectives: To evaluate the results of the inoperable and operable with aortic valve endocarditis, focus on risk factors, significance, and management of destruction of the aortic annulus in aortic valve endocarditis.

Methods: The retrospective study was completed to investigate patients with aortic valve endocarditis undergoing cardiac surgery between January 2006 and November 2022 at our hospital.

Results: 512 patients were divided into group with destruction of the aortic annulus (n = 80) and without destruction of the aortic annulus (n = 432). There were 32 operative deaths (6.3%, 32/512). By univariate and multivariate analysis, destruction of the aortic annulus is found to be statistically significantly associated with in-hospital mortality (P < 0.001), prolonged mechanical ventilation time (mechanical ventilation time > 96 h, P = 0.018), early aortic paravalvular leak (P < 0.001), and 1-year mortality following cardiac surgery (P < 0.001), respectively.

Conclusions: In our study, destruction of the aortic annulus increases mortality and health care costs. Optimization of pre-, peri-, and postoperative factors can reduce mortality and morbidity in aortic valve endocarditis. Aortic root replacement could be recommended as the best practice choice for aortic valve endocarditis with periannular abscess and destruction of the aortic annulus.

1 Introduction

Infective endocarditis (IE) is defined by a focus of infection within the heart and is a feared disease across the field of cardiology. Even at experienced centers, operations for IE remain associated with the highest mortality of any valve disease. Approximately half of all IE patients are identified as high-risk and undergo operative treatment. Destruction of the aortic annulus, which is caused by aortic periannular abscess or aortic root abscess, is a severe complication of aortic valve endocarditis. Surgical treatment of aortic valve endocarditis with destruction of the aortic annulus is a challenging issue with high mortality and morbidity rate in the current era (13).

In our cohort, the main reasons for perioperative death were paravalvular leaks and septic shock with consecutive multiorgan failure and cerebral hemorrhage. One of the most frequent determinants of paravalvular leaks is destruction of the aortic annulus in aortic valve endocarditis. However, only a few reports in the available literature evaluated the incidence and predictors for destruction of the aortic annulus in aortic valve endocarditis (4). We aimed to evaluate the results of the inoperable and operable with aortic valve endocarditis, focus on risk factors, significance, and management of destruction of the aortic annulus in aortic valve endocarditis.

We hypothesized that optimization of pre-, peri-, and postoperative factors can reduce mortality and morbidity in aortic valve endocarditis.

2 Patients and methods

2.1 Design

The retrospective study was completed to investigate patients with aortic valve endocarditis undergoing cardiac surgery between January 2006 and November 2022 at our hospital. Medical records were reviewed.

2.2 Diagnosis

Patients were diagnosed according to the modified Duke criteria (5). Surgical and pathological findings were reviewed to confirm the preoperative diagnosis.

2.3 Eligibility criteria

Inclusion criteria included patients with aortic valve endocarditis undergoing cardiac surgery between January 2006 and November 2022 at our hospital. Exclusion criteria included patients without aortic valve endocarditis (Figure 1).

Figure 1
www.frontiersin.org

Figure 1. Flow chart of clinical trial. During the study period, 944 patients were diagnosed as aortic valve endocarditis, with 272 multiorgan failure at admission, 512 undergoing surgery, 64 receiving only medical therapy, and 96 refusal surgery.

2.4 Surgical technique

Cardiac surgery for IE was indicated according to AATS guidelines for the management of IE. Radical debridement of all infected tissues and foreign material is followed by generous irrigation. Allografts are preferred for aortic root reconstruction in patients with annulus destruction (1).

2.5 Peri- and postoperative management

All patients were transferred to the intensive care unit after the operation. Anticoagulation management was conducted routinely. Transthoracic echocardiograph was performed postoperatively 1 to 7 days in intensive care unit.

2.6 Variables to be analyzed

Variables were evaluated (Supplementary Material).

Time between symptoms and admission was defined as length from onset of symptoms to the date of admission.

Time between symptoms and surgery was defined as length from onset of symptoms to the date of operation.

In-hospital mortality was defined as death within 30 days of the operation or during the same hospital admission.

In our study, serum creatinine was used as the diagnostic standard of acute renal injury. According to Kidney Disease Improving Global Outcomes (KDIGO) classification, if serum creatinine increases by ≥0.3 mg/dl (26.5 μmol/L) within 48 h, serum creatinine is 50% higher than the baseline within first seven days, or urine output is below 0.5 ml/kg/hour for six hours, the patient is considered to have acute renal injury (5).

Multiorgan failure (MOF) is regarded as a continuous process of varying levels of organ failure rather than an all-or-none event. Lungs, cardiovascular system, kidneys, liver, coagulation system, and central nervous system are regarded as “key organs” to characterize MOF (6).

Hepatic failure is defined as a severe liver injury, potentially reversible in nature and with onset of hepatic encephalopathy within 8 weeks of the first symptoms in the absence of pre-existing liver disease (7).

Respiratory failure is defined as a condition in which the respiratory system fails in one or both of its gas exchange functions, i.e., oxygenation of and/or elimination of carbon dioxide from mixed venous blood. It is defined by an arterial oxygen tension (Pa, O2) of ≤8.0 kPa (60 mmHg), an arterial carbon dioxide tension (Pa, CO2) of ≥6.0 kPa (45 mmHg) or both (8).

2.7 Follow-up

All survivors discharged from hospital were monitored to the end date of the study. At the outpatient department, all patients were investigated with echocardiogram, electrocardiogram, and x-ray chest film, once every 3 to 12 months. At the last follow-up, the patients were contacted by telephone or micro-message or interviewed directly at the outpatient department.

2.8 Statistical analyses

Continuous variables are reported as means ± SE. A normality test was performed for all variables in the study by Kolmogorov-Smirnov test. Survival rates were estimated using the Kaplan-Meier method. The chi-square test, the Kruskal-Walls test or the Wilcoxon rank-sum test, as appropriate, was used to evaluate relationships between the preoperative variables, and selected intraoperative and postoperative variables. The relationships with perioperative risk factors were assessed by means of contingency table methods and logistic regression analysis. Survival analysis was performed by Kaplan–Meier analysis, and differences in survival between groups were examined with the log-rank test. Multivariate Cox proportional hazard models were used. P values less than 0.05 were statistically significant. All analyses were performed using IBM SPSS version 24.0 software (IBM SPSS Inc., USA).

2.9 Ethical approval

The experiment protocol for involving humans was in accordance to Helsinki Statement and national guidelines and was approved by the Medical Ethics Committee of The People's Hospital of Guangxi Zhuang Autonomous Region, and They gave the authors approval to waive the need for patient consent for publishing data in the study about the patients.

3 Results

3.1 Multiorgan failure at admission in aortic valve endocarditis

During the study period, 944 patients were diagnosed as aortic valve endocarditis, with 272 (28.8%, 272/944) excluded from surgery because of multiorgan failure at admission, 512 (54.2%, 512/944) undergoing surgery, 64 (6.8%, 64/944) receiving only medical therapy because of the absence of surgical indication, and 96 (10.2%, 96/944) being excluded from surgery, despite surgical indication, because of refusal of relatives (Figure 1).

Body weight (58.97 ± 0.28 vs. 55.14 ± 0.45 kg, P < 0.001), time between symptoms and admission (3.09 ± 0.13 vs. 2.32 ± 0.09 months, P < 0.001), vegetation length (14.42 ± 0.29 vs. 10.26 ± 0.23 mm, P < 0.001), aortic insufficiency (8.86 ± 0.53 vs. 5.68 ± 0.24 cm2, P < 0.001), and symptomatic neurological complications (47.1 vs. 11.9%, P < 0.001) in group of multiorgan failure at admission were significantly higher than those in group of non-multiorgan failure (Table 1).

Table 1
www.frontiersin.org

Table 1. Multiorgan failure at admission in aortic valve endocarditis.

3.2 Analysis of risk factors of multiorgan failure at admission in aortic valve endocarditis (n = 432)

Univariate analysis showed that factors are associated with multiorgan failure at admission, including body weight (P < 0.001), time between symptoms and admission (P = 0.037), vegetation length (P < 0.001), aortic insufficiency (P < 0.001), and symptomatic neurological complications (P < 0.001).

When they were included in multivariate analysis models, multivariate analyses also showed that factors are associated with multiorgan failure at admission, including body weight (P < 0.001), time between symptoms and admission (P < 0.001), vegetation length (P < 0.001), aortic insufficiency (P < 0.001), and symptomatic neurological complications (P < 0.001) (Table 2).

Table 2
www.frontiersin.org

Table 2. Analysis of risk factors for multiorgan failure at admission in aortic valve endocarditis (n = 272).

3.3 Successful only medical therapy in aortic valve endocarditis

64 patients were successfully treated only by medical therapy in aortic valve endocarditis. Time between symptoms and admission (1.0 ± 0.1 vs. 2.7 ± 0.2 months, P < 0.001) and vegetation length (5.4 ± 0.2 vs. 10.4 ± 0.9 mm, P < 0.001) in group of successful only medical therapy were significantly less than both in group of cardiac surgery (Table 3).

Table 3
www.frontiersin.org

Table 3. Successful only medical therapy and refusal surgery in aortic valve endocarditis.

3.4 Operative data

512 patients with aortic valve endocarditis undergoing cardiac surgery were divided into group with destruction of the aortic annulus (n = 80) and without destruction of the aortic annulus (n = 432). There were 32 operative deaths (6.3%, 32/512) (Tables 4, 5).

Table 4
www.frontiersin.org

Table 4. Preoperative, operative and follow-up data (n = 512).

Table 5
www.frontiersin.org

Table 5. Operation in aortic valve endocarditis (n = 512).

Weight (62.6 ± 0.58 vs. 53.22 ± 0.58 kg, P < 0.001), vegetation length (13.2 ± 0.48 vs. 10.3 ± 0.33 mm, P < 0.001), preoperative left ventricular end diastolic dimension (70.6 ± 0.67 vs. 62.77 ± 0.40 mm, P < 0.001), preoperative aortic insufficiency (12.2 ± 0.30 vs. 8.43 ± 0.32 cm2, P < 0.001), serum creatinine before surgery (105.6 ± 3.92 vs. 80.15 ± 1.21 μmol/L, P < 0.001) in group with destruction of the aortic annulus were significantly higher than those in group without destruction of the aortic annulus (Table 4).

3.5 Resource utilization

Aortic cross-clamp time (122.8 ± 3.56 vs. 93.19 ± 1.63 min, P < 0.001), cardiopulmonary bypass time (209.8 ± 5.8 vs. 145.3 ± 2.15 min, P < 0.001), mechanical ventilation time (73.2 ± 5.66 vs. 51.91 ± 2.64 h, P < 0.001), ICU retention time (7.0 ± 0.19 vs. 5.19 ± 0.15 days, P < 0.001), hospitalized time postoperative (21.2 ± 1.04 vs. 19.15 ± 0.4 days, P = 0.047), serum creatinine 24 h after surgery (134.8 ± 7.27 vs. 91.89 ± 1.72 μmol/L, P < 0.001), serum creatinine 48 h after surgery (150.2 ± 11.6 vs. 110.78 ± 2.84 μmol/L, P < 0.001), chest drainage (786.0 ± 41.14 vs. 668.5 ± 16.48 ml, P = 0.006), postoperative LVEDD (55.0 ± 0.64 vs. 48.58 ± 0.34 mm, P < 0.001), fresh-frozen plasma (930.0 ± 36.5 vs. 684.4 ± 19.62 ml, P < 0.001), Fresh-frozen plasma (930.0 ± 36.53 vs. 684.4 ± 19.62 ml, P < 0.001), and packed red cells (4.2 ± 0.35 vs. 2.67 ± 0.12 units, P < 0.001) in group with destruction of the aortic annulus were significantly higher than those in group without destruction of the aortic annulus (Table 4).

Fluid balance on 1st day postoperative (−440.0 ± 63.19 vs. −674.1 ± 62.85 ml, P < 0.001) and fluid balance on 2nd day (−200.0 ± 31.82 vs. −492.6 ± 40.1 ml, P < 0.001) postoperative in group with destruction of the aortic annulus was significantly less negative than that in group without destruction of the aortic annulus (Table 4).

The common early postoperative complications included acute renal injury (159/512, 31.1%), long-term intubation time >48 h (230/512, 44.9%), and multiorgan failure (52/512, 10.2%).

3.6 Analysis of risk factors for destruction of the aortic annulus

Univariate analysis of potential risk factors for destruction of the aortic annulus in patients with aortic valve endocarditis showed that numerous factors are associated with destruction of the aortic annulus, including body weight (P < 0.001), vegetation length (P < 0.001), preoperative aortic insufficiency (P < 0.001), preoperative left ventricular end diastolic dimension (P < 0.001), and serum creatinine before surgery (P < 0.001).

When they were included in multivariate analysis models, multivariate analyses also showed that numerous factors are associated with destruction of the aortic annulus, including body weight (P < 0.001), vegetation length (P < 0.001), preoperative aortic insufficiency (P < 0.001), preoperative left ventricular end diastolic dimension (P < 0.001), and serum creatinine before surgery (P < 0.001) (Table 6).

Table 6
www.frontiersin.org

Table 6. Analysis of risk factors for destruction of the aortic annulus in aortic valve endocarditis.

3.7 Analysis of significance of destruction of the aortic annulus in aortic valve endocarditis

Univariate and multivariate analysis of risk factors of in-hospital mortality, prolonged mechanical ventilation time (mechanical ventilation time >96 h), prolonged ICU retention time, early aortic paravalvular leak following cardiac surgery, and 1-year mortality following cardiac surgery in aortic valve endocarditis showed that destruction of the aortic annulus is statistically significantly associated with in-hospital mortality (P < 0.001), prolonged mechanical ventilation time (mechanical ventilation time >96 h, P = 0.018), early aortic paravalvular leak (P < 0.001), and 1-year mortality following cardiac surgery (P < 0.001), respectively (Table 7).

Table 7
www.frontiersin.org

Table 7. Analysis of the significance of destruction of the aortic annulus in aortic valve endocarditis (n = 512).

3.8 Follow-up results

480 survivors were discharged and 460 patients were monitored to the end date of the study and the follow-up was 95.8% (460/480) completed. The mean duration of follow-up was 74.96 ± 2.44 months. 55 deaths (55/460, 12.0%) occurred within 12 months after being discharged because of recurrence of IE and cerebral hemorrhage. The latest data of follow-up showed that 373 survivors were in NYHA class I (373/405, 92.1%) and 32 in class II (32/405, 7.9%). The presence of destruction of the aortic annulus in the setting of infective endocarditis significantly increased in-hospital mortality, and was also a significant risk factor for long-term survival. Univariate and multivariate analysis of Cox proportional hazard regression for all-time mortality indicated that numerous factors are associated with all-time mortality, including age (P < 0.001), body weight (P < 0.001), vegetation length (P < 0.001), preoperative aortic insufficiency (P < 0.001), ICU retention time (P < 0.001), serum creatinine 48 h after surgery (P < 0.001), postoperative left ventricular end diastolic dimension (P < 0.01), and packed red cells (P < 0.001) (Figure 2, Table 8).

Figure 2
www.frontiersin.org

Figure 2. Kaplan–Meier curve for survival. Blue line, Group 1: Group with destruction of the aortic annulus. Green line, Group 2: Group without destruction of the aortic annulus.

Table 8
www.frontiersin.org

Table 8. Cox proportional hazard regression for all-time mortality.

4 Discussion

The present study aimed to evaluate the results of the inoperable and operable with aortic valve endocarditis, focus on risk factors, significance, and management of destruction of the aortic annulus in aortic valve endocarditis. We identified that destruction of the aortic annulus increases mortality and health care costs; optimization of pre-, peri-, and postoperative factors can reduce mortality and morbidity in aortic valve endocarditis; and aortic root replacement could be recommended as the best practice choice for aortic valve endocarditis with periannular abscess and destruction of the aortic annulus.

In our study, only 54.2% (512/944) patients with aortic valve endocarditis underwent surgery, and 28.8% (272/944) were excluded from surgery because of multiorgan failure at admission. Time between symptoms and admission is associated with multiorgan failure at admission. Vegetation length, aortic insufficiency, and symptomatic neurological complications are parameter of severity of disease. Vegetation length is associated with multiorgan failure at admission, destruction of the aortic annulus in aortic valve endocarditis and all-time mortality. Therefore, early diagnosis and treatment of aortic valve endocarditis are important, and early surgical intervention is advocated, as aortic valve endocarditis is a progressive and life-threatening disease. Reaching a rapid and accurate diagnosis in cases of aortic valve endocarditis is still a central challenge of the disease. Delayed diagnosis and initiation of therapy lead to complications and worse clinical outcomes. Because of lack of excellent network of primary, secondary, and tertiary prevention, these patients therefore present late in the hospital and are usually diagnosed and transferred to our tertiary hospital late. A conceptual framework comprising of required baseline information and requirements for executing primary, secondary, and tertiary prevention has been advocated as a best model for aortic valve endocarditis control.

Follow-up data about morbidity and mortality indicated that almost all the deaths occurred within 12 months of surgery, which means all patients discharged from hospital must be followed up closely. Vegetation length, preoperative aortic insufficiency, serum creatinine 48 h after surgery, postoperative left ventricular end diastolic dimension, and packed red cells are associated with all-time mortality, therefor, early diagnosis and initiation of therapy to avoid larger vegetation length and preoperative aortic insufficiency, and excellent protection for the kidney, heart, and blood have significant implication for long-term outcomes.

4.1 Destruction of the aortic annulus increases mortality and health care costs

The presence of a paravalvular abscess or destruction of aortic annulus is a crucial indication for surgical management due to its known association with high in-hospital mortality. Periannular abscess or destruction of aortic annulus occurs in more than 10% of patients with aortic valve endocarditis. The previous study indicated that about 22% of patients who suffered from aortic valve endocarditis had periannular abscess and destruction of aortic annulus. Another study reported periannular extension, including abscess, pseudoaneurysm and fistula accounted for 37% of left-sided endocarditis (4, 910). Delayed surgery may lead to further damage to the aortic root, with a higher risk of complications and a more complex surgical process. Despite progress in treatment, the associated incidence rate and mortality rates are still high, indicating the need for more effective interventions. Generally speaking, in these cases, the main goal of surgery is to thoroughly debride the infected tissue, reconstruct the excised area, and replace the aortic valve or aortic root. The choice of aortic valve replacement or aortic root replacement for annulus reconstruction depends on the degree of annulus destruction. Aortic root replacement surgery has been the main choice in recent studies (11). In our study, 15.6% (80/512) of patients with aortic valve endocarditis suffered from periannular abscess and destruction of aortic annulus. The presence of destruction of the aortic annulus in the setting of infective endocarditis significantly increased in-hospital and long-term mortality.

Complex infection of the aortic valve with aortic root involvement and destruction of aortic annulus remains a grave challenge to the cardiac surgeon. Patients frequently present profoundly unwell and extensive surgery may be required to correct the underlying anatomical deficits and provide source control in septic patients. Complex aortic valve endocarditis with aortic root involvement and destruction of aortic annulus continues to have a high in-hospital mortality rate of 10% to 40% (1115). Improvement of surgical and perfusion techniques can decrease aortic cross-clamp time, cardiopulmonary bypass time, intubation time, ICU retention time, hospitalized time postoperative, paravalvular leak, chest drainage, fresh-frozen plasma, and packed red cells, therefor, contribute to better clinical outcomes.

4.2 Prevention of destruction of the aortic annulus

Preoperative LVEDD, vegetation length, preoperative aortic insufficiency, and serum creatinine before surgery are all parameter of severity of aortic valve endocarditis. Our present study showed that vegetation length and preoperative aortic insufficiency are associated with destruction of the aortic annulus in patients with aortic valve endocarditis. Therefore, early diagnosis and treatment of IE are important. Early surgical intervention is advocated, as aortic valve endocarditis is a progressive and life-threatening disease, and patients with a poor preoperative functional class are at the highest risk for in-hospital death. Early diagnosis and treatment maybe prevent the development of periannular abscess and destruction of aortic annulus.

4.3 Management of destruction of the aortic annulus

Surgical treatment of aortic valve endocarditis with aortic periannular abscess and destruction of the aortic annulus is still a challenging issue with high mortality and morbidity rate in the current era. Surgical method such as aortic valve replacement and aortic root replacement or reconstruction depend on the integrity of aortic annulus. According to the guideline of the Society of Thoracic Surgeons Clinical Practice, if the aortic annulus is healthy and strong enough for suture, it is reasonable to use a mechanical or stented tissue valve following radical debridement completed. If the aortic annulus is disrupted, aortic root replacement or reconstruction is usually the preferred choice of surgery (16, 17).

There is more and more evidence to indicate that aortic root replacement is associated with advantageous reoperation rates and rate of early paravalvular leak, a hypothesis that is also intuitive and backed by well-established surgical principles. Patients treated with an aortic root replacement were at a lower risk of reoperation and rate of early paravalvular leak at 1-year follow-up.

Destruction of the aortic annulus is associated with early aortic paravalvular leak, in-hospital mortality, and 1-year mortality. The main reasons of in-hospital mortality were early paravalvular leak and sepsis. Early paravalvular leak occurred mainly in patients with destruction of the aortic annulus treated with 6.0 Prolene sutures and patch reconstruction (early aortic paravalvular leak, 29.7%, 19/64). A paravalvular leak (PVL) is an incomplete apposition of a heart valve prosthesis on the native valve annulus, with a residual leakage between the artificial valve and the patient's native valve ring. This complication is the most common form of nonstructural valve dyfunction observed after a heart valve replacement. In Bentall procedure, a self-assembled composite graft allows safe proximal fixation of the conduit in patients with destroyed aortic annulus, resulting in sufficient proximal anastomosis and a very low incidence of aorta-related reoperations.Aortic paravalvular leak generally do not occur in aortic root replacement (Bentall procedure). It is reportet that modified Bentall procedure could have a role in effectively reducing paravalvular leak in aortic regurgitation related to Behcet's disease (1821).

Aortic root replacement accomplishes more comprehensive removal of infected tissue and reconstruction of cardiac morphology compared with aortic valve replacement and therefor can attain lower rates of reinfection and graft deterioration. The aortic root replacement technique is related to an advantageous postoperative profile compared with aortic valve replacement. Aortic root replacement could be recommended as the best practice choice for aortic valve endocarditis with periannular abscess and destruction of the aortic annulus (2225).

4.4 Perspectives

How to prevent multiorgan failure at admission and optimally treat destruction of the aortic annulus in aortic valve endocarditis remains grave challenge to us. Network of primary, secondary, and tertiary prevention and early diagnosis and treatment of aortic valve endocarditis will contribute to better short and long-term outcomes.

4.5 Strengths and limitations of the study

Our study for the first time clarified the risk factors, significance, and management of destruction of the aortic annulus in aortic valve endocarditis, adding value to the existing literature. Limitations of the present study include its retrospective design. There may be a selection bias because of the retrospective nature of the study and our hospital as a tertiary referral center. Well-designed research such as prospective cohort studies are needed and programs aiming at the reduction of in-hospital morbidity and mortality caused by aortic valve endocarditis are encouraged. The results and analysis of patients operated for aortic valve endocarditis is also very conflicting. Most of the risk factor CI interval is <1 suggesting they are protective. This needs to be re-evaluated. The diagnose of aortic root destruction was made during cardiac surgery, and the incidence of aortic root destruction in patients who had multiorgan failure at presentation and patients who refused surgery remained unknown.

5 Conclusions

In our study, destruction of the aortic annulus increases mortality and health care costs. Optimization of pre-, peri-, and post-operative factors can reduce mortality and morbidity in aortic valve endocarditis. Aortic root replacement could be recommended as the best practice choice for aortic valve endocarditis with periannular abscess and destruction of the aortic annulus.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by Medical Ethics Committee of The People's Hospital of Guangxi Zhuang Autonomous Region. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements.

Author contributions

JH: Conceptualization, Funding acquisition, Writing – original draft. CL: Investigation, Validation, Writing – review & editing. ZD: Supervision, Writing – review & editing. JY: Investigation, Supervision, Writing – review & editing. JL: Supervision, Validation, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article.

This work was supported by the Natural Science Foundation of China (No: 81360014), the Natural Science Foundation of Guangxi (No: 2014GXNSFAA118234), the Guangxi key scientific and technological project (No: 2013BC26236), and the Projects in Guangxi Health Department (No: GZPT13-27).

Acknowledgments

We thank Li and Long for their help.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2023.1296557/full#supplementary-material

References

1. Pettersson GB, Hussain ST. Current AATS guidelines on surgical treatment of aortic valve endocarditis. Ann Cardiothorac Surg. (2019) 8(6):630–44. doi: 10.21037/acs.2019.10.05

PubMed Abstract | Crossref Full Text | Google Scholar

2. Williams ML, Brookes JDL, Jaya JS, Tan E. Homograft versus valves and valved conduits for extensive aortic valve endocarditis with aortic root involvement/destruction: a systematic review and meta-analysis. Aorta (Stamford). (2022) 10(2):43–51. doi: 10.1055/s-0042-1743110

PubMed Abstract | Crossref Full Text | Google Scholar

3. Straw S, Baig MW, Mishra V, Gillott R, Witte KK, Van Doorn C, et al. Surgical techniques and outcomes in patients with intra-cardiac abscesses complicating aortic valve endocarditis. Front Cardiovasc Med. (2022) 9:875870. doi: 10.3389/fcvm.2022.875870

PubMed Abstract | Crossref Full Text | Google Scholar

4. Harris WM, Sinha S, Caputo M, Angelini GD, Ahmed EM, Rajakaruna C, et al. Surgical outcomes and optimal approach to treatment of aortic valve endocarditis with aortic root abscess. J Card Surg. (2022) 37(7):1917–25. doi: 10.1111/jocs.16464

PubMed Abstract | Crossref Full Text | Google Scholar

5. Howitt SH, Grant SW, Caiado C, Carlson E, Kwon D, Dimarakis I, et al. The KDIGO acute kidney injury guidelines for cardiac surgery patients in critical care: a validation study. BMC Nephrol. (2018) 19(1):149. doi: 10.1186/s12882-018-0946-x

PubMed Abstract | Crossref Full Text | Google Scholar

6. Durham RM, Moran JJ, Mazuski JE, Shapiro MJ, Baue AE, Flint LM. Multiple organ failure in trauma patients. J Trauma. (2003) 55(4):608–16. doi: 10.1097/01.TA.0000092378.10660.D1

PubMed Abstract | Crossref Full Text | Google Scholar

7. Bernal W, Wendon J. Acute liver failure. N Engl J Med. (2013) 369:2525–34. doi: 10.1056/NEJMra1208937

PubMed Abstract | Crossref Full Text | Google Scholar

8. Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J Suppl. (2003) 47:3s–14s. doi: 10.1183/09031936.03.00038503

PubMed Abstract | Crossref Full Text | Google Scholar

9. Huang JB, Wen ZK, Lu CC, Yang JR, Li JJ. Risk factors of prolonged intensive care unit stay following cardiac surgery for infective endocarditis. Medicine (Baltimore). (2023) 102(38):e35128. doi: 10.1097/MD.0000000000035128

PubMed Abstract | Crossref Full Text | Google Scholar

10. Yang B, Caceres J, Farhat L, Le T, Brown B, St. Pierre E, et al. Root abscess in the setting of infectious endocarditis: short and long-term outcomes. J Thorac Cardiovasc Surg. (2021) 162(4):1049–59.e1. doi: 10.1016/j.jtcvs.2019.12.140

PubMed Abstract | Crossref Full Text | Google Scholar

11. Croon SI, Angkasuwan A, van Straten AH, Khamooshian A, Elenbaas TW, Soliman-Hamad MA. Surgical treatment and long-term outcome of aortic valve endocarditis with periannular abscess. Neth Heart J. (2020) 28(6):345–53. doi: 10.1007/s12471-020-01409-x

PubMed Abstract | Crossref Full Text | Google Scholar

12. Qamar F, Attar RH, Nabi F. Paravalvular leak. Methodist DeBakey Cardiovasc J. (2022) 18(1):7–9. doi: 10.14797/mdcvj.1096

PubMed Abstract | Crossref Full Text | Google Scholar

13. Anguera I, Miro JM, Cabell CH, Abrutyn E, Fowler VG Jr, Hoen B, et al. Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the international collaboration on endocarditis merged database. Am J Cardiol. (2005) 96(07):976–81. doi: 10.1016/j.amjcard.2005.05.056

PubMed Abstract | Crossref Full Text | Google Scholar

14. Anguera I, Miro JM, Evangelista A, Cabell CH, San Roman JA, Vilacosta I, et al. Periannular complications in aortic valve endocarditis involving native aortic valves. Am J Cardiol. (2006) 98(09):1254–60. doi: 10.1016/j.amjcard.2006.06.016

PubMed Abstract | Crossref Full Text | Google Scholar

15. Jassar AS, Bavaria JE, Szeto WY, Moeller PJ, Maniaci J, Milewski RK, et al. Graft selection for aortic root replacement in complex active endocarditis: does it matter? Ann Thorac Surg. (2012) 93(02):480–7. doi: 10.1016/j.athoracsur.2011.09.074

PubMed Abstract | Crossref Full Text | Google Scholar

16. Knosalla C, Weng Y, Yankah AC, Siniawski H, Hofmeister J, Hammerschmidt R, et al. Surgical treatment of active infective aortic valve endocarditis with associated periannular abscess:11-year results. Eur Heart J. (2000) 21(06):490–7. doi: 10.1053/euhj.1999.1877

PubMed Abstract | Crossref Full Text | Google Scholar

17. Leontyev S, Davierwala PM, Krögh G, Feder S, Oberbach A, Bakhtiary F, et al. Early and late outcomes of complex aortic root surgery in patients with aortic root abscesses. Eur J Cardiothorac Surg. (2016) 49(2):447–54; discussion 454–5. doi: 10.1093/ejcts/ezv138

PubMed Abstract | Crossref Full Text | Google Scholar

18. Li N, Peng J, Tan M, Bai Y, Qiao F, Han Q, et al. Clinical outcome of reoperation for mechanical prosthesis at aortic position. Heart Lung Circ. (2021) 30(7):1084–90. doi: 10.1016/j.hlc.2021.01.002

PubMed Abstract | Crossref Full Text | Google Scholar

19. Hu HO, Zhang CH, Spadaccio C, Tang B, Li CN, Qiao ZY, et al. Surgical management of aortic regurgitation secondary to Behcet’s disease. Front Cardiovasc Med. (2023) 10:1093024. doi: 10.3389/fcvm.2023.1093024

PubMed Abstract | Crossref Full Text | Google Scholar

20. Urbanski PP, Lakew F, Dinstak W, Heinz N, Zacher M, Irimie V, et al. Bentall procedure after previous aortic valve or complete root replacement: usefulness of self-assembled aortic valve conduit. J Thorac Cardiovasc Surg. (2018) 156(1):89–95.e2. doi: 10.1016/j.jtcvs.2018.01.105

PubMed Abstract | Crossref Full Text | Google Scholar

21. Bouhout I, Mazine A, Ghoneim A, Millàn X, El-Hamamsy I, Pellerin M, et al. Long-term results after surgical treatment of paravalvular leak in the aortic and mitral position. J Thorac Cardiovasc Surg. (2016) 151:1260–6.e1. doi: 10.1016/j.jtcvs.2015.11.046

PubMed Abstract | Crossref Full Text | Google Scholar

22. Huang JB, Lu CC, Wen ZK, Yang JR, Li JJ, Lu CC. Impact of vegetation length on clinical complications during surgical intervention and long-term survival in infective endocarditis. Am J Cardiol. (2023) 201:335–40. doi: 10.1016/j.amjcard.2023.06.019

PubMed Abstract | Crossref Full Text | Google Scholar

23. Musci M, Weng Y, Hübler M, Amiri A, Pasic M, Kosky S, et al. Homograft aortic root replacement in native or prosthetic active aortic valve endocarditis: twenty-year single-center experience. J Thorac Cardiovasc Surg. (2010) 139:665–73. doi: 10.1016/j.jtcvs.2009.07.026

PubMed Abstract | Crossref Full Text | Google Scholar

24. Huang JB, Lu CC, Wen ZK, Yang JR, Li JJ. Surgical treatment of left-sided infective endocarditis with symptomatic neurological complications before surgery in China. Front Cardiovasc Med. (2023) 10:1217148. doi: 10.3389/fcvm.2023.1217148

PubMed Abstract | Crossref Full Text | Google Scholar

25. Chen GJ, Lo WC, Tseng HW, Pan SC, Chen YS, Chang SC. Outcome of surgical intervention for aortic root abscess: a meta-analysis. Eur J Cardiothorac Surg. (2018) 53(4):807–14. doi: 10.1093/ejcts/ezx421

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: aortic valve endocarditis, surgery, destruction of the aortic annulus, operable, inoperable

Citation: Huang J-b, Lu C-c, Du Z-z, Yang J-r and Li J-j (2024) Results of the inoperable and operable with aortic valve endocarditis. Front. Cardiovasc. Med. 10:1296557. doi: 10.3389/fcvm.2023.1296557

Received: 18 September 2023; Accepted: 29 December 2023;
Published: 16 January 2024.

Edited by:

Maurizio Taramasso, University Hospital Zürich, Switzerland

Reviewed by:

Pankaj Garg, Mayo Clinic Florida, United States
Julio Garcia, University of Calgary, Canada

© 2024 Huang, Lu, Du, Yang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jing-bin Huang hjb010222@163.com

These authors have contributed equally to this work

Abbreviations CT, computed tomography; CPB, cardiopulmonary bypass; ICU, intensive care unit; IE, infective endocarditis; MOF, multiple organ failure; ECMO, extracorporeal membrane oxygenation; LVEF, left ventricular ejection fractions; AKI, acute renal injury; AKIN, acute kidney injury network; LVEDD, left ventricular end diastolic dimension.

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.